1. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at: http://aidsinfo.nih.gov/contentFiles/adultandadolescentGL.pdf. Accessed May 4, 2014.
2. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel;Thompson;JAMA,2012
3. HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure;Swenson;AIDS,2014
4. Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients;Delaugerre;PLoS One,2012
5. Ribaudo H, Lennox J, Currier J, et al. Virologic failure endpoint definition in clinical trials: is using HIV-RNA threshold <200 copies/mL better than <50 copies/mL? An analysis of ACTG studies. 16th Conference on Retroviruses and Opportunistic Infections. Monteal (Canada), February 8–11, 2009.